Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2001; 37:300-307
© 2001 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schäfer, M.
Right arrow Articles by Schlüter, K.-D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schäfer, M.
Right arrow Articles by Schlüter, K.-D.

Beta-adrenoceptor stimulation attenuates the hypertrophic effect of alpha-adrenoceptor stimulation in adult rat ventricular cardiomyocytes

Matthias Schäfer, PhD*, Klaus Pönicke, PhD{dagger}, Ingrid Heinroth-Hoffmann, PhD{dagger}, Otto-Erich Brodde, PhD*, Hans Michael Piper, MD, PhD* and Klaus-Dieter Schlüter, PhD*

* Physiologisches Institut, Justus-Liebig-Universität Giessen, Giessen, Germany
{dagger} Institut fur, Pharmakologie und Toxikologie, Martin-Luther-Universität Halle, Halle, Germany



View larger version (24K):

[in a new window]
 
Figure 1 Incorporation of 3H-phenylalanine (Phe) of cardiomyocytes cultured for 20 h in the presence of norepinephrine (NOR) at concentrations indicated (open bars) and (A) in the presence of prazosin (0.1 µmol/liter; filled bars) or (B) propranolol (1 µmol/liter; filled bars). Data are expressed as percentages relative to the control values. Data are means ± SEM from n = 8 cultures. * = p < 0.05 vs. each other; ** = p < 0.01 vs. each other; n.d. = not determined.

 


View larger version (24K):

[in a new window]
 
Figure 2 Incorporation of 3H-phenylalanine (Phe) of cardiomyocytes cultured for 20 h in the presence of norepinephrine (NOR, open bars) at concentrations indicated, in the presence of NOR and CPG 20712A (300 nmol/liter; filled bars) or in the presence of NOR and ICI 118,551 (55 nmol/liter; hatched bars). Data are expressed as percentages relative to the control values. Data are means ± SEM from n = 8 cultures. * = p < 0.05 vs. each other; ** = p < 0.01 vs. each other.

 


View larger version (20K):

[in a new window]
 
Figure 3 Incorporation of 14C-phenylalanine (Phe) of cardiomyocytes cultured for 24 h in the presence of norepinephrine (NOR) at concentrations indicated (open bars) or NOR and atenolol (1 µmol/liter; filled bars). Data are expressed as percentages relative to the control values. Data are means ± SEM from n = 6 cultures. * = p < 0.05 vs. each other.

 


View larger version (32K):

[in a new window]
 
Figure 4 Incorporation of 14C-phenylalanine (Phe) and protein mass (protein/DNA ratio) of cardiomyocytes cultured for 24 h in presence of phenylephrine (PE, 10 µmol/liter), norepinephrine (NOR, 1 µmol/liter), or NOR and atenolol (ATE, 1 µmol/liter). Data are expressed as percentages relative to the control values. Data are means ± SEM from n = 6 cultures. * = p < 0.05 vs. control; # = p < 0.05 vs. NOR. Open bars = PE; filled bars = NOR; hatched bars = ATE + NOR.

 


View larger version (30K):

[in a new window]
 
Figure 5 Incorporation of 14C-uridine (Uri) and RNA mass (RNA/DNA ratio) of cardiomyocytes cultured in presence of phenylephrine (PE, 10 µmol/liter), norepinephrine (NOR, 1 µmol/liter), or NOR and atenolol (ATE, 1 µmol/liter). Cells were incubated with the agonists for 6 h in case of RNA synthesis and 24 h in case of RNA mass. Data are expressed as percentages relative to the control values. Data are means ± SEM from n = 6 cultures. * = p < 0.05 vs. C; # = p < 0.05 vs. NOR. Open bars = PE; filled bars = NOR; hatched bars = ATE + NOR.

 


View larger version (34K):

[in a new window]
 
Figure 6 (A) Western blots indicating the translocation of protein kinase C (PKC) isoforms {alpha} and {delta} into the particular fraction. Cells were incubated for 5 min (control, C), with norepinephrine (NOR, 1 µmol/liter) or norepinephrine and atenolol (NOR + Ate, 1 µmol/liter). (B) Incorporation of 14C-phenylalanine (Phe) of cardiomyocytes cultured for 24 h in presence of phenylephrine (PE, 10 µmol/liter), phorbol myristate acetate (PMA, 0.1 µmol/liter), or PE and PMA in co-presence of isoprenaline (1 µmol/liter) and ICI 118,551 (ICI, 0.1 µmol/liter) (ISO + ICI). Data are expressed as percentages relative to the control values. Data are means ± SEM from n = 6 cultures. * = p < 0.05 vs. each other.

 


View larger version (21K):

[in a new window]
 
Figure 7 Incorporation of 14C-phenylalanine (Phe) of cardiomyocytes cultured for 24 h in presence of norepinephrine (NOR, 1 µmol/liter), phenylephrine (PE, 10 µmol/liter), or PE in co-presence of isoprenaline (1 µmol/liter) and ICI 118,551 (ICI, 0.1 µmol/liter) (ISO + ICI). Where indicated Rp-cAMPS (RpcAMPS, 10 µmol/liter) or dibutyryl-cAMP (dbcAMP, 1 mmol/liter) was added. Data are expressed as percentages relative to the control values. Data are means ± SEM from n = 6 cultures. * = p < 0.05 vs. each other.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement